Paper Assesses Effectiveness of HCV Treatments

Recently posted by the federal Agency for Healthcare Research and Quality, the paper says antiviral therapy for chronic hepatitis C virus infection continues to evolve.

The federal Agency for Healthcare Research and Quality has posted a recently published paper reviewing the effectiveness of treatments being administered to people with chronic hepatitis C. The authors say no study has evaluated the comparative effectiveness of current antiviral regimens on long-term clinical outcomes such as mortality, complications of chronic HCV infection, or quality of life.

Patients with HCV who achieved a sustained virologic response (SVR) -- undetectable levels of the virus six months after completing treatment -- have a lower risk of death than those who do not achieve it, according to the research review from AHRQ’s Effective Health Care Program, which is published in Comparative Effectiveness Reviews, No. 76.

HCV, the most common chronic bloodborne pathogen, is associated with an estimated 15,000 U.S. deaths per year. The review compares the effectiveness of dual- and triple-drug combinations in achieving the desired SVR.

Antiviral therapy for chronic hepatitis C virus (HCV) infection continues to evolve. Acknowledging trials would be difficult to design and carry out because of the long time required for complications of chronic HCV infection to develop in most patients, the authors said it is critical that future studies evaluate clinical outcomes in patients with SVR versus no SVR after antiviral therapy and adequately control for other factors that influence clinical outcomes in chronic HCV infection.

To read the full paper, visit http://www.ncbi.nlm.nih.gov/books/NBK115347/.

Product Showcase

  • HAZ LO HEADLAMPS

    With alkaline or rechargeable options, these safety rated, Class 1, Div. 1 Headlamps provide long runtime with both spot and flood options in the same light. Work safely and avoid trip hazards with flexible hands-free lighting from Streamlight. Read More

  • Full Line of Defense Against Combustible Dust Nilfisk

    Nilfisk provides a comprehensive range of industrial vacuums meticulously crafted to adhere to NFPA 652 housekeeping standards, essential for gathering combustible dust in Class I, Group D, and Class II, Groups E, F & G environments or non-classified settings. Our pneumatic vacuums are meticulously engineered to fulfill safety criteria for deployment in hazardous surroundings. Leveraging advanced filtration technology, Nilfisk ensures the secure capture of combustible materials scattered throughout your facility, ranging from fuels, solvents, and metal dust to flour, sugar, and pharmaceutical powders. Read More

  • Glove Guard® Clip

    Safety should never be compromised, especially when it comes to proper glove usage. The Glove Guard® clip enhances safety by encouraging employees to keep their gloves with them at all times. This reduces the risk of accidents and injuries on the job. By ensuring everyone has their gloves readily available, we help promote a culture of safety and efficiency. The Glove Guard® clip is designed to withstand the toughest work environments. Constructed from robust materials made in the USA, it can endure extreme conditions, including harsh weather, and rigorous activities. Read More

Featured

Webinars